Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease

BACKGROUND: Bacterial infections are involved in more than a half of the exacerbations of chronic obstructive pulmonary disease (COPD). AIM: To evaluate the efficacy and safety of moxifloxacin in the outpatient treatment of moderate exacerbations of bacterial origin in the COPD patients. METHODS: We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Access Maced J Med Sci
Autors principals: Minov, Jordan, Stoleski, Sasho, Petrova, Tatjana, Vasilevska, Kristin, Mijakoski, Dragan, Bislimovska-Karadzhinska, Jovanka
Format: Artigo
Idioma:Inglês
Publicat: Republic of Macedonia 2018
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290446/
https://ncbi.nlm.nih.gov/pubmed/30559853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2018.445
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars